THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS

THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS

Show other versions (1)

<p><strong>Aim.</strong> To evaluate antianginal and antiischemic activity of molsidomine (Corvaton) in stable angina pectoris of II-III functional class (FC).</p><p><strong>Material and methods.</strong> 45 patients with II FC (31 persons) and III FC of ang...

Full description

Bibliographic Details
Main Authors: I. I. Sinitsina, V. A. Orlov, G. U. Zacharova, T. A. Gembitskaya
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
стенокардия напряжения
молсидомин
толерантность к физической нагрузке
Online Access:http://www.rpcardio.ru/jour/article/view/406
id doaj-f4c983b635794e74a70362444a1aa063
record_format Article
spelling doaj-f4c983b635794e74a70362444a1aa0632020-11-24T21:36:21ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-12-0132202510.1234/1819-6446-2007-2-20-25406THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORISI. I. Sinitsina0V. A. Orlov1G. U. Zacharova2T. A. Gembitskaya3Российская медицинская академия последипломного образования, МоскваРоссийская медицинская академия последипломного образования, МоскваРоссийская медицинская академия последипломного образования, МоскваРоссийская медицинская академия последипломного образования, Москва<p><strong>Aim.</strong> To evaluate antianginal and antiischemic activity of molsidomine (Corvaton) in stable angina pectoris of II-III functional class (FC).</p><p><strong>Material and methods.</strong> 45 patients with II FC (31 persons) and III FC of angina (14 persons) were included into the study. All patients took molsidomine in individual doses during 3 months. Antianginal and antiischemic activity of molsidomine was estimated by veloergometric tests.</p><p><strong>Results.</strong> Molsidomine therapy resulted in disappearance of angina pectoris in 41, 7% of patients with stable angina of II-III FC and reduction of ST depression.</p><p><strong>Conclusion.</strong> Molsidomine is an effective antianginal and antiischemic medicine in patients with stable angina of II-III FC and provides the stable effect during long-term usage.</p>http://www.rpcardio.ru/jour/article/view/406стенокардия напряжениямолсидоминтолерантность к физической нагрузке
collection DOAJ
language English
format Article
sources DOAJ
author I. I. Sinitsina
V. A. Orlov
G. U. Zacharova
T. A. Gembitskaya
spellingShingle I. I. Sinitsina
V. A. Orlov
G. U. Zacharova
T. A. Gembitskaya
THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS
Racionalʹnaâ Farmakoterapiâ v Kardiologii
стенокардия напряжения
молсидомин
толерантность к физической нагрузке
author_facet I. I. Sinitsina
V. A. Orlov
G. U. Zacharova
T. A. Gembitskaya
author_sort I. I. Sinitsina
title THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS
title_short THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS
title_full THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS
title_fullStr THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS
title_full_unstemmed THE EXPERIENCE OF MOLSIDOMINE USAGE IN PATIENTS WITH STABLE ANGINA PECTORIS
title_sort experience of molsidomine usage in patients with stable angina pectoris
publisher Stolichnaya Izdatelskaya Kompaniya
series Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn 1819-6446
2225-3653
publishDate 2015-12-01
description <p><strong>Aim.</strong> To evaluate antianginal and antiischemic activity of molsidomine (Corvaton) in stable angina pectoris of II-III functional class (FC).</p><p><strong>Material and methods.</strong> 45 patients with II FC (31 persons) and III FC of angina (14 persons) were included into the study. All patients took molsidomine in individual doses during 3 months. Antianginal and antiischemic activity of molsidomine was estimated by veloergometric tests.</p><p><strong>Results.</strong> Molsidomine therapy resulted in disappearance of angina pectoris in 41, 7% of patients with stable angina of II-III FC and reduction of ST depression.</p><p><strong>Conclusion.</strong> Molsidomine is an effective antianginal and antiischemic medicine in patients with stable angina of II-III FC and provides the stable effect during long-term usage.</p>
topic стенокардия напряжения
молсидомин
толерантность к физической нагрузке
url http://www.rpcardio.ru/jour/article/view/406
work_keys_str_mv AT iisinitsina theexperienceofmolsidomineusageinpatientswithstableanginapectoris
AT vaorlov theexperienceofmolsidomineusageinpatientswithstableanginapectoris
AT guzacharova theexperienceofmolsidomineusageinpatientswithstableanginapectoris
AT tagembitskaya theexperienceofmolsidomineusageinpatientswithstableanginapectoris
AT iisinitsina experienceofmolsidomineusageinpatientswithstableanginapectoris
AT vaorlov experienceofmolsidomineusageinpatientswithstableanginapectoris
AT guzacharova experienceofmolsidomineusageinpatientswithstableanginapectoris
AT tagembitskaya experienceofmolsidomineusageinpatientswithstableanginapectoris
_version_ 1725941545019899904

Similar Items